Literature DB >> 15744512

[Early diagnosis of liver diseases].

M M Dollinger1, L Fechner, W E Fleig.   

Abstract

In Germany, liver diseases are the leading cause of death through illness among 30 to 45 year olds. Most are chronic diseases and timely preventative or therapeutic measures could avert their manifestation or at least the following complications. Currently, screening for liver diseases is focused on specific groups at risk such as patients with alcohol abuse, relatives of patients with a genetic disease or individuals at risk of an infection with a viral hepatitis. For some diseases, studies have been started to test the practicability of population screening, which has already been successfully implemented for Hepatitis B and C in blood donors. Screening is also recommended for advanced liver disease. It helps to detect the development of cirrhosis and its complications namely varices and hepatocellular carcinoma.

Entities:  

Mesh:

Year:  2005        PMID: 15744512     DOI: 10.1007/s00108-005-1378-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  17 in total

1.  The diagnosis of cirrhosis by high resolution ultrasound of the liver surface.

Authors:  V Simonovský
Journal:  Br J Radiol       Date:  1999-01       Impact factor: 3.039

Review 2.  Wilson disease.

Authors:  Jonathan D Gitlin
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

Review 3.  Prenatal diagnosis for alpha1-antitrypsin deficiency.

Authors:  Diane W Cox
Journal:  Prenat Diagn       Date:  2004-06       Impact factor: 3.050

Review 4.  Review article: the evolving role of liver biopsy.

Authors:  M S Campbell; K R Reddy
Journal:  Aliment Pharmacol Ther       Date:  2004-08-01       Impact factor: 8.171

Review 5.  [Diagnosis, progression and therapy of hepatitis-B-virus infection--results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and and in cooperation with the Hepatitis Competence Network].

Authors:  M P Manns; H Wedemeyer; S Meyer; M Roggendorf; C Niederau; H E Blum; W Jilg; W E Fleig
Journal:  Z Gastroenterol       Date:  2004-08       Impact factor: 2.000

Review 6.  [Criteria for the definition of acute and chronic hepatitis C].

Authors:  W E Fleig; P Krummener; J Lesske
Journal:  Z Gastroenterol       Date:  2004-08       Impact factor: 2.000

Review 7.  [Diagnosis, progression and therapy of hepatitis C virus infection as well as viral infection in children and adolescents--results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and and in cooperation with the Hepatitis Competence Network].

Authors:  W E Fleig; P Krummenerl; J Lesske; H P Dienes; S Zeuzem; W-H Schmiegel; D Häussinger; M Burdelski; M P Manns
Journal:  Z Gastroenterol       Date:  2004-08       Impact factor: 2.000

Review 8.  Clinical aspects of fatty liver disease.

Authors:  Jayanta Choudhury; Arun J Sanyal
Journal:  Semin Liver Dis       Date:  2004-11       Impact factor: 6.115

Review 9.  Diagnosis and therapy of alcoholic liver disease.

Authors:  Josh Levitsky; Mark E Mailliard
Journal:  Semin Liver Dis       Date:  2004-08       Impact factor: 6.115

Review 10.  Screening in liver disease: report of an AASLD clinical workshop.

Authors:  Paul C Adams; Michael J Arthur; Thomas D Boyer; Laurie D DeLeve; Adrian M Di Bisceglie; Mark Hall; Theodore R Levin; Dawn Provenzale; Leonard Seeff
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.